Mark Cuban’s Pharmacy Adds Another Onc Drug: Capecitabine
Rena Conti, TPRI Faculty Director, quoted in Medscape, May 26, 2023.
Category: All Articles
The Optimist’s Guide to Artificial Intelligence and Work
James Bessen, TPRI Executive Director, research cited in The New York Times, May 20, 2023.
Will Short-Term Financial Pressures Complicate the Transition to Sustainable Business Models?
Timothy Simcoe, TPRI Faculty Director, quoted in the MIT Sloan Management Review, April 26, 2023.
Is Big Tech’s R&D Spending Actually Hurting Innovation in the U.S.?
James Bessen, TPRI Executive Director, quoted in The Wall Street Journal, April 8, 2023.
Have Uber and Netflix Lost Their First-Mover Advantage?
Timothy Simcoe, TPRI Faculty Director, co-organized the survey question of the month and shared the survey results in the MIT Sloan Management Review, March 31, 2023.
BU Social Scientists Rank Among Top 2% of Highly Cited Scholars
James Bessen ranked in the top 2% social science scholars by citations BU Arts & Sciences Center for Innovation in Social Sciences, March 29, 2023.
The New Goliaths: How Corporations Use Software to Dominate Industries, Kill Innovation, and Undermine Regulation
James Bessen, TPRI Executive Director’s, new book featured in Politics Today, March 6, 2023.
Will Generative AI Create a New Era of Search Competition?
Timothy Simcoe, TPRI Faculty Director, co-organized the survey question of the month and shared the survey results in the MIT Sloan Management Review, February 28, 2023.
Humira Rivals Set to Try to Drive Down Cost of Blockbuster Drug
Rena Conti quoted in Bloomberg Law, January 31, 2023.
Technology Is Not Failing—It is transforming the Economy
James Bessen’s OpEd article ‘Technology Is Not Failing—It is transforming the Economy” in The Nikkei, January 20, 2023, and in the Organization for Economic Cooperation and Development (OECD) Forum Network, January 24, 2023.